M. Saito et al., EFFECT OF ISCHEMIA-REPERFUSION ON CONTRACTILE FUNCTION OF RAT URINARY-BLADDER - POSSIBLE ROLE OF NITRIC-OXIDE, Life sciences, 62(11), 1998, pp. 149-156
Citations number
16
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Because there are increasing evidences that nitric oxide (NO) plays im
portant roles in ischemia-reperfusion injury in several systems, we in
vestigated the role of NO in ischemia-reperfusion injury of the rat ur
inary bladder. Rat abdominal aorta was clamped with a small clip to in
duce ischemia-reperfusion injury in the rat bladder dome. In functiona
l studies, contractile responses to carbachol were cumulatively measur
ed after the urinary bladder was treated with various duration (0, 30,
60, and 90 min) of ischemia. The injury of rat bladder functioning wa
s dependent on ischemic periods. Significant decreases in the E-max (m
aximum contractile response) values were observed in the bladder subje
cted to 60 or 90 min ischemia. Furthermore, the subsequent 30 min repe
rfusion caused additional damages of the contractile response in bladd
er muscles. To investigate the role of NO in the ischemia (30 min)-rep
erfusion (30 min) injury, N-G-nitro-L-arginine methylester (L-NAME) wa
s injected intraperitoneally 30 min before the ischemia. Treatment of
L-NAME (30 and 100 mg/kg) partly but significantly prevented the reduc
tion contractile responses to carbachol of the rat bladder dome. In hi
stological studies, the ischemia-reperfusion caused infiltration of le
ukocytes and rupture of microcirculation in the regions of submucosa a
nd smooth muscle without a corresponding sloughing of mucosal cells. T
he histological damages were also prevented by treatment with L-NAME.
Therefore; these data suggested that ischemia-reperfusion of the urina
ry bladder may result in dysfunction of the contractile response to au
tonomic nervous system and that nitric oxide may act as a cell/tissue
damaging agent in ischemia-reperfusion injury. (C) 1998 Elsevier Scien
ce Inc.